-
Who will be the big winner in the first imitation snatch battle in 2022?
Time of Update: 2022-08-19
It is reported that among the 6 first imitations, nimodipine oral solution, ondansetron oral dissolving film, tacrolimus sustained-release capsule, and acetaminophen mannitol injection are new dosage forms .
-
Press the speed-up button for the centralized collection of dental implants, and the price reduction is already on the way!
Time of Update: 2022-08-19
Recently, the National Medical Insurance Bureau issued the "Notice on Carrying out the Investigation and Registration of Oral Implant Charges and Medical Service Prices", which means that there has been an important advance in the centralized procurement of dental implants .
-
State Food and Drug Administration: Anastomotic Reinforcement Patch Approved for Market
Time of Update: 2022-08-19
Recently, the State Drug Administration approved the registration of the innovative product "Anastomosis Reinforcement Patch" produced by Beijing Bohui Ruijin Biotechnology Co.
Recently, the State Drug Administration approved the registration of the innovative product "Anastomosis Reinforcement Patch" produced by Beijing Bohui Ruijin Biotechnology Co.
-
In order to develop the main business, another pharmaceutical company sells a house!
Time of Update: 2022-08-19
According to the announcement of Foci Pharmaceuticals, in order to effectively revitalize the company's existing assets, focus on the main business of pharmaceuticals, and reduce the company's financial pressure, the company plans to transfer two lands located in Anning District, Lanzhou City to the controlling shareholder Foci Pharmaceutical Group at a price of 103 million yuan .
-
The prospect of the traditional Chinese medicine market is optimistic, and pharmaceutical companies are accelerating the layout of the whole industry chain
Time of Update: 2022-08-19
For example, recently, Wanbangde said in an investor survey that in the future, the company's pharmaceutical manufacturing sector will focus on the traditional Chinese medicine industry, jointly develop traditional Chinese medicine products, sort out the existing 24 traditional Chinese medicine products and carry out secondary research and development, and will not rule out mergers and acquisitions.
-
A Perspective on Further Perfecting and Implementing Positive Fertility Support Measures
Time of Update: 2022-08-19
children It is worth noting that in response to the new needs of young pregnant women, the guidelines propose to expand the pilot of labor analgesia, standardize related diagnosis and treatment behaviors, and improve the level of labor analgesia .
-
Here's your chance for a medical representative!
Time of Update: 2022-08-19
A large number of domestic and foreign pharmaceutical companies are recruiting (Photo source: Pharmaceutical Network) The author saw from the public information of a recruitment website that recently, including GSK China, AstraZeneca China, Pfizer, Abbott (Shanghai), Zhifei Bio, Tide Pharmaceutical, etc.
-
The GEM IPO of the subsidiary company that was spun off by the head pharmaceutical company of the big infusion solution has passed!
Time of Update: 2022-08-19
From the perspective of financial data, the annual report of Kelun Pharmaceutical disclosed that from 2016 to 2018, the operating income realized by Twinings Biotechnology showed a growth trend, increasing from 1.
-
The pattern of improved new drug application has changed!
Time of Update: 2022-08-19
The second category in the chemical drug registration classification, that is, the improved new drugs that have not been marketed at home and abroad, refers to the optimization of their structure, dosage form, prescription process, route of administration, indications, etc.
-
Since August, the good news of the clinical approval of new drugs by pharmaceutical companies has continued!
Time of Update: 2022-08-19
Sinovac Pharmaceuticals On August 2, Kexing Pharmaceutical announced that the clinical trial application for PEGylated human granulocyte stimulating factor injection submitted by the company has been accepted .
-
Since the beginning of this year, a large number of pharmacies in many places have withdrawn from medical insurance
Time of Update: 2022-08-19
After on-site verification and reporting to the relevant competent authorities, it plans to terminate the service agreement with 109 medical insurance designated retail pharmacies including Zhengkang Pharmacy in Zhongkai High-tech Zone, Huizhou City .
-
After the centralized collection of insulin, Novo Nordisk, Tonghua Dongbao, and Gan Li were all under pressure!
Time of Update: 2022-08-19
In recent years, new hypoglycemic drugs, glucagon-like peptide-1 (GLP-1) receptor agonists, have shown strong competitiveness, not only in the field of diabetes treatment, but also in metabolic diseases such as weight loss .
-
The top in vitro diagnostic companies reported outstanding performance in the interim report, and the growth rate of the two companies exceeded 100%
Time of Update: 2022-08-16
Regarding the reasons for the growth in performance, the company stated that during the reporting period, the company provided nucleic acid detection products as one of the core suppliers of domestic new crown nucleic acid diagnosis products; market demand for 2019-nCoV nucleic acid detection kits, nucleic acid detection instruments, and related consumables continued.
-
Behind the dazzling performance of the leading pharmaceutical equipment companies, the diversified business layout opens up more room for growth
Time of Update: 2022-08-16
The industry believes that under this background, with a high level of innovation and R&D, and outstanding product quality and manufacturing and processing capabilities, leading pharmaceutical equipment companies with a diversified and international layout are expected to open up long-term growth space .
-
During the year, a large number of core technical personnel of pharmaceutical companies resigned, and there is no shortage of those with annual salary of nearly one million
Time of Update: 2022-08-16
On the evening of August 1, Kain Technology announced that Hou Jianhua, the company's core technical staff, resigned due to personal reasons .
On the evening of August 1, Kain Technology announced that Hou Jianhua, the company's core technical staff, resigned due to personal reasons .
-
The domestic ADC drug market is fiercely competitive, and pharmaceutical companies set off a fever to go overseas
Time of Update: 2022-08-16
On July 26, Kelun Biotech, a subsidiary of Kelun Pharmaceutical, and Merck, a US pharmaceutical company, reached a cooperation agreement on ADC drugs for the treatment of solid tumors, authorizing the latter's global rights and interests in an early-stage biological macromolecule tumor project B; the agreement stipulated that, Colombo will receive an upfront payment of $35 million and milestone payments of up to $901 million .
-
More than 10 pharmaceutical companies announced their "transcripts" in the first half of the year, and many net profits doubled
Time of Update: 2022-08-16
In the first half of 2022, the company achieved revenue of 642 million yuan, a year-on-year increase of 41.
In the first half of 2022, the company achieved revenue of 642 million yuan, a year-on-year increase of 41.
-
With the accelerated reform of the pharmaceutical industry, win-win cooperation is increasingly favored by enterprises
Time of Update: 2022-08-16
In fact, in order to enhance the expansion of the research and development pipeline and accelerate the commercialization of products, it has become more and more common in the industry to join forces between pharmaceutical companies .
-
The semi-annual reports of traditional Chinese medicine companies have successively disclosed that the R&D investment in the first half of the year has increased significantly
Time of Update: 2022-08-16
Under the continuous investment in research and development, Zhongsheng Pharmaceutical has a steady development momentum, of which the Chinese patent medicine business achieved sales of 853 million yuan, a year-on-year increase of 8.
-
Hebei Pharmaceutical is booming, and the added value of the pharmaceutical manufacturing industry in the first half of the year increased by 15%
Time of Update: 2022-08-16
In terms of operating income, in the first half of this year, 415 enterprises in the pharmaceutical industry above designated size in Hebei achieved a year-on-year increase of 9.
